<?xml version="1.0" encoding="UTF-8"?>
<p>Fifth, some of the drugs used in MS therapy (interferon-Î², glatiramer acetate) do not increase the risk of infection, and hence they can be considered during therapy initiation and can be continued as well. Drugs with a low risk of systemic immunosuppression (dimethyl fumarate, teriflunomide) can be safe to start, but treatment continuation requires regular monitoring of leukocyte count, which may be difficult during an ongoing pandemic.</p>
